CHARLESTON, S.C. (WCIV) -- There's new hope for Americans who suffer from a rare form of Cystic Fibrosis.{} The Food and Drug Administration approved the drug Kalydeco. The drug, previously known as ...
ProQR Therapeutics N.V. announced that clinical study PQ-010-002, a proof-of-concept study of nasal potential difference (NPD), demonstrated that QR-010 restored CFTR function in a cohort of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results